Back to search

Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028.

Data up to Jan 2025

Published2015
Citations86
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer… (2015) – Journal of Clinical Oncology | Metascience Observatory Explorer